Skip to content
lifestyle.phenomena.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Harbour Biomed
Harbour BioMed and Sinopharm Enter Strategic Collaboration to Establish Innovation R&D Consortium
July 27, 2026
Harbour BioMed Announces Positive Profit Alert for 2026 Interim Results, Marking Seventh Consecutive Profitable Half-Year as Platform-Based Advantages Drive Sustainable Growth
July 23, 2026
Harbour BioMed and Kelun-Biotech Announce NMPA Approval of IND Application for HBM7575/SKB575 for the Treatment of Asthma
July 15, 2026
Harbour BioMed Appoints Dr. Lloyd Klickstein as Scientific Advisor for Immunology
June 28, 2026
Harbour BioMed Announces Promising Preclinical Data for LET003, Its First AI-Enabled Drug Candidate
May 17, 2026
Harbour BioMed Announces U.S. FDA IND Clearance for HBM7004 for the Treatment of Advanced Solid Tumors
May 8, 2026
Nona Biosciences Appoints Dr. Josh Xiao as Chief Scientific Officer to Advance Global Scientific Strategy and Innovation
May 6, 2026
Nona Biosciences Evolves Brand to Reflect Next Phase of Growth in Biotherapeutic Innovation
May 5, 2026
Harbour BioMed Appoints Dr. Adam Zong as President
April 16, 2026
Harbour BioMed Reports Full Year 2025 Financial Results: Sustained Global Collaboration Underpins Long-Term Growth
March 30, 2026
1
2
Next Page
→